Is IL-1β a Target for Reducing Hospitalization of Infants Infected with Respiratory Syncytial Virus?
Am J Respir Cell Mol Biol
.
2022 Mar;66(3):248-249.
doi: 10.1165/rcmb.2021-0457ED.
Authors
Yohannes A Mebratu
1
,
Yohannes Tesfaigzi
1
Affiliation
1
Pulmonary and Critical Care Medicine Brigham and Women's Hospital and Harvard Medical School Boston, Massachusetts.
PMID:
34905715
PMCID:
PMC8937241
DOI:
10.1165/rcmb.2021-0457ED
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Hospitalization
Humans
Infant
Respiratory Syncytial Virus Infections* / virology
Respiratory Syncytial Virus, Human*
Grants and funding
R01 AI148180/AI/NIAID NIH HHS/United States
R01 HL068111/HL/NHLBI NIH HHS/United States